You are here: Industry Insights > antibiotic

News List

Iterum Therapeutics Presents Data on Prevalence of Resistant Infections and Activity of its Novel Antibiotic Sulopenem biospace
April 23, 2018
Iterum Therapeutics plc, will deliver a mini-oral presentation and two additional posters at the European Congress of Clinical Microbiology in Madrid, Spain from April 21 to 24, 2018.
Test for antibiotic associated kidney damage in children with CF identified europeanpharmaceuticalreview
April 02, 2018
New research highlights effective methods for identifying a common side effect in children receiving drug treatments for Cystic fibrosis…
Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections biospace
March 27, 2018
Based in Lorrach, Germany and Saint Louis, France, Allecra Therapeutics releasedpositive top-line data from its Phase II trial of AAI101, an antibiotic against gram-negative bacteria.
Scientists develop rapid test that determines antibiotic resistance europeanpharmaceuticalreview
March 20, 2018
Scientists in Germany have developed a test using electric fields and Raman spectroscopy to ascertain specific antibiotic resistance of pathogens and thus enable the prescription of effective treatment.
Sanofi in talks with Evotec to out-licence antibiotic research pharmaphorum
March 12, 2018
Sanofi is in talks with the German biotech Evotec to out-license most of its infectious disease R&D, including novel antimicrobial research.
Nanoparticles as a solution against antibiotic resistance? worldpharmanews
December 18, 2017
Around one in 3,300 children in Germany is born with Mucoviscidosis. A characteristic of this illness is that one channel albumen on the cell surface is disturbed by mutations
FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; i worldpharmanews
December 14, 2017
Today the U.S. Food and Drug Administration is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to health care professionals as part of an overall effort to combat antimicrobial resistance.
€3.6 million Horizon 2020 Phase II grant secured by Symcel in battle against antibiotic resistance pharmaasia
November 28, 2017
The aim is for multi-resistant bacterial sepsis infections to be validated utilising the sensitive Symcel screening technology.
FDA Berates Lupin for Repeatedly Making Pills That Don't Meet Quality Standards biospace
November 17, 2017
Lupin Ltd., which makes generic antibiotics, antidepressants and heart medications for sale in the U.S., was warned by the Food and Drug Administration for repeatedly ignoring tests showing that pills made at two of its facilities didn’t meet quality stan
Helperby Therapeutics develops sustainable solution for antibiotic resistance biospectrumasia
November 15, 2017
Antibiotic Resistance Breakers is a novel technology that rejuvenates existing antibiotics into long-term effective combination therapies

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page